A technician works in the inoculation area during preparations to produce vaccines for the H1N1 flu virus at a lab in Wuhan, Hubei province June 17, 2009. Chinese vaccine maker Sinovac Biotech Ltd hopes to put its H1N1 vaccine through its first clinical trial by the end of July, as pharmaceutical firms race to put vaccines against the new flu virus into commercial production. Thousands of chicken eggs were readied to grow the H1N1 virus on Monday, after the World Health Organization declared a pandemic last Thursday and warned governments to prepare for a long battle against the virus. Picture taken June 17, 2009. REUTERS/China Daily (CHINA HEALTH SOCIETY SCI TECH BUSINESS)
Post a Comment
CFR seeks to foster civil and informed discussion of foreign policy issues. Opinions expressed on CFR blogs are solely those of the author or commenter, not of CFR, which takes no institutional positions. All comments must abide by CFR's guidelines and will be moderated prior to posting.